-
Something wrong with this record ?
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
DP. McLornan, R. Szydlo, M. Robin, A. van Biezen, L. Koster, HJP. Blok, MT. Van Lint, J. Finke, A. Vitek, K. Carlson, L. Griskevicius, E. Holler, M. Itälä-Remes, M. Schaap, G. Socié, JO. Bay, Y. Beguin, B. Bruno, JJ. Cornelissen, T. Gedde-Dahl,...
Language English Country England, Great Britain
Document type Journal Article
PubMed
29808926
DOI
10.1111/bjh.15407
Knihovny.cz E-resources
- MeSH
- Survival Analysis MeSH
- Adult MeSH
- Drug Therapy MeSH
- Transplantation, Homologous MeSH
- Middle Aged MeSH
- Humans MeSH
- Disease Management MeSH
- Primary Myelofibrosis mortality therapy MeSH
- Recurrence MeSH
- Retrospective Studies MeSH
- Lymphocyte Transfusion MeSH
- Hematopoietic Stem Cell Transplantation methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) remains the only curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the outcome and, indeed, management of those MF patients who relapse following transplant. We hereby report on the management and outcome of 202 patients who relapsed post allo-HSCT for MF.
CHU de Lille LIRIC INSERM U995 Universite de Lille Lille France
Clinic for Cancer Surgery and Transplantation Oslo University Hospital Rikshospitalet Norway
Comprehensive Cancer Centre Division of Haematology King's College London
Department of Haematology and Oncology University of Regensburg Regensburg Germany
Department of Haematology Hopital d`Enfants Nancy France
Department of Haematology Karolinska University Hospital Stockholm Sweden
Department of Haematology Radboud University Medical Centre Nijmegen the Netherlands
Department of Haematology University of Liege Liege Belgium
Division of Haematology Geneva University Hospitals Geneva Switzerland
EBMT Data Office University Medical Centre Leiden the Netherlands
Erasmus MC Cancer Institute University Medical Centre Rotterdam the Netherlands
Hammersmith Hospital NHS Foundation Trust London United Kingdom
Institute of Haematology and Blood Transfusion Prague Czech Republic
Ospedale San Martino Genova Italy
Service d'hématologie clinique Adulte et pédiatrie CHU ESTAING Clermont France
Service d'Hématologie Greffe Hôpital Saint Louis Assistance Publique Hôpitaux de Paris Paris France
Stem Cell Transplant Unit Turku University Hospital Turku Finland
University Hospital Eppendorf Hamburg Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028409
- 003
- CZ-PrNML
- 005
- 20190822083354.0
- 007
- ta
- 008
- 190813s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/bjh.15407 $2 doi
- 035 __
- $a (PubMed)29808926
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a McLornan, Donal P $u Comprehensive Cancer Centre, Division of Haematology, King's College, London.
- 245 10
- $a Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT / $c DP. McLornan, R. Szydlo, M. Robin, A. van Biezen, L. Koster, HJP. Blok, MT. Van Lint, J. Finke, A. Vitek, K. Carlson, L. Griskevicius, E. Holler, M. Itälä-Remes, M. Schaap, G. Socié, JO. Bay, Y. Beguin, B. Bruno, JJ. Cornelissen, T. Gedde-Dahl, P. Ljungman, MT. Rubio, I. Yakoub-Agha, E. Klyuchnikov, E. Olavarria, Y. Chalandon, N. Kröger,
- 520 9_
- $a Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) remains the only curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the outcome and, indeed, management of those MF patients who relapse following transplant. We hereby report on the management and outcome of 202 patients who relapsed post allo-HSCT for MF.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a farmakoterapie $7 D004358
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a transplantace hematopoetických kmenových buněk $x metody $7 D018380
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a transfuze lymfocytů $7 D017710
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a primární myelofibróza $x mortalita $x terapie $7 D055728
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a analýza přežití $7 D016019
- 650 _2
- $a homologní transplantace $7 D014184
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Szydlo, Richard $u Hammersmith Hospital NHS Foundation Trust, London, United Kingdom.
- 700 1_
- $a Robin, Marie $u Service d'Hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.
- 700 1_
- $a van Biezen, Anja $u EBMT Data Office, University Medical Centre, Leiden, the Netherlands.
- 700 1_
- $a Koster, Linda $u EBMT Data Office, University Medical Centre, Leiden, the Netherlands.
- 700 1_
- $a Blok, Henrik J P $u EBMT Data Office, University Medical Centre, Leiden, the Netherlands.
- 700 1_
- $a Van Lint, Maria T $u Ospedale San Martino, Genova, Italy.
- 700 1_
- $a Finke, Jürgen $u University of Freiburg, Freiburg, Germany.
- 700 1_
- $a Vitek, Antonin $u Institute of Haematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Carlson, Kristina $u University Hospital Uppsala, Uppsala, Sweden.
- 700 1_
- $a Griskevicius, Laimonas $u Haematology, Oncology& Transfusion Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
- 700 1_
- $a Holler, Ernst $u Department of Haematology and Oncology, University of Regensburg, Regensburg, Germany.
- 700 1_
- $a Itälä-Remes, Maija $u Stem Cell Transplant Unit, Turku University Hospital, Turku, Finland.
- 700 1_
- $a Schaap, Michel $u Department of Haematology, Radboud University Medical Centre, Nijmegen, the Netherlands.
- 700 1_
- $a Socié, Gerard $u Service d'Hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.
- 700 1_
- $a Bay, Jacques-Olivier $u Service d'hématologie clinique Adulte et pédiatrie, CHU ESTAING, Clermont, France.
- 700 1_
- $a Beguin, Yves $u Department of Haematology, University of Liege, Liege, Belgium.
- 700 1_
- $a Bruno, Benedetto $u A.O.U Citta della Salute e della Scienza di Torino, S.S.C.V.D Trapianto di Cellule Staminali, Torino, Italy.
- 700 1_
- $a Cornelissen, Jan J $u Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands.
- 700 1_
- $a Gedde-Dahl, Tobias $u Clinic for Cancer, Surgery and Transplantation, Oslo University Hospital, Rikshospitalet, Norway.
- 700 1_
- $a Ljungman, Per $u Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Rubio, Marie T $u Department of Haematology, Hopital d`Enfants, Nancy, France.
- 700 1_
- $a Yakoub-Agha, Ibrahim $u CHU de Lille, LIRIC, INSERM U995, Universite de Lille, Lille, France.
- 700 1_
- $a Klyuchnikov, Evgeny $u University Hospital Eppendorf, Hamburg, Germany.
- 700 1_
- $a Olavarria, Eduardo $u Hammersmith Hospital NHS Foundation Trust, London, United Kingdom.
- 700 1_
- $a Chalandon, Yves $u Division of Haematology, Geneva University Hospitals, Geneva, Switzerland.
- 700 1_
- $a Kröger, Nicolaus $u University Hospital Eppendorf, Hamburg, Germany.
- 773 0_
- $w MED00009374 $t British journal of haematology $x 1365-2141 $g Roč. 182, č. 3 (2018), s. 418-422
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29808926 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190822083632 $b ABA008
- 999 __
- $a ok $b bmc $g 1433558 $s 1066869
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 182 $c 3 $d 418-422 $e 20180529 $i 1365-2141 $m British journal of haematology $n Br J Haematol $x MED00009374
- LZP __
- $a Pubmed-20190813
